Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × Chalazion × Clear all

Phase

Phase NA 7 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 948 Carcinoma, Non-Small-Cell Lung 596 Neoplasms 468 Prostatic Neoplasms 427 Colorectal Neoplasms 365 Multiple Myeloma 286 Lung Neoplasms 256 Neoplasm Metastasis 254 Leukemia, Myeloid, Acute 226 Stomach Neoplasms 216 Carcinoma, Hepatocellular 215 Ovarian Neoplasms 187 Rectal Neoplasms 179 Lymphoma, Follicular 170 Lymphoma 169 Colonic Neoplasms 168 Leukemia 154 Pancreatic Neoplasms 150 Uterine Cervical Neoplasms 148 Head and Neck Neoplasms 146 Lymphoma, Non-Hodgkin 145 Lymphoma, Large B-Cell, Diffuse 137 Recurrence 136 Leukemia, Lymphocytic, Chronic, B-Cell 136 Precursor Cell Lymphoblastic Leukemia-Lymphoma 134 Melanoma 133 Brain Neoplasms 126 Squamous Cell Carcinoma of Head and Neck 122 Urinary Bladder Neoplasms 120 Pain 120

Interventions

Triamcinolone Acetonide 1 Triamcinolone 1 Fluorouracil 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡